On February 17, 2021, the United States Court of Appeals for the Fourth Circuit has upheld a prior $15 million jury verdict in which the sellers of the VSL#3® probiotic were found liable for false advertising under the Lanham Act. This judgement confirms the findings from a 2018 jury trial in [...]
On November 18, 2018, the Maryland Court of Justice condemned the pharmaceutical companies, VSL. Inc., Leadiant and Alfasigma, distributors of the probiotic VSL#3, to pay $15 million for false advertising and having deceived patients and doctors. As a result of this court decision, scientific authorities now recognize the De Simone Formulation [...]
A federal jury in the United States District Court for the District of Maryland unanimously ruled on Nov. 18 in favor of myself and ExeGi Pharma, which distributes my Formulation in the US, against VSL Inc, Leadiant and Alfasigma, for False Advertising, Unjust Enrichment and Unpaid Royalties. The jury unanimously found [...]